Articles tagged as

Food and Drug Administration

  1. The Industry Handbook: Pharma Industry

  2. Gilead's 3 Most Profitable Lines of Business (GILD)

  3. The Biggest Risks of Investing in Johnson & Johnson Stock (JNJ)

  4. The Biggest Risks of Investing in Celgene Stock (CELG)

  5. The Biggest Risks of Investing in Altria Stock (MO)

  6. The Top 5 Health Care Penny Stocks for 2016 (CRIS, GERN)

  7. The Top 5 Mid-Cap Biotechnology Stocks for 2016 (ALNY, ICPT)

  8. SBIO: ALPS Medical Breakthroughs ETF

  9. PPH: Market Vectors Pharmaceutical ETF

  10. The Biggest Risks of Investing in Pfizer Stock (PFE)

  11. How Will e-cigarettes Affect Big Tobacco? (RAI, PM)

  12. Celgene Vs. Gilead: Vetting for the Best Biopharma

  13. 10 Developments By Gilead Sciences That Could Boost Profits (GILD)

  14. How to Profit from the Generic Drug Trend

  15. How Does Biogen Make its Money?

  16. How NDAs Work and Why They're Important

  17. Could Amgen's Next Drug Be Worth $100 Billion?

  18. 3 Things That Could Hold Intuitive Surgical Back

  19. Did Orexigen Make A Big Mistake?

  20. Are These Biogen Idec's Next Blockbusters?

  21. Why Does Wall Street Hate MannKind?

  22. What’s The Drug That Will Finally Fight Obesity?

  23. Is Ariad On Track To Lose More Shares?

  24. What Is Amgen’s New Target?

  25. Will MannKind Finally Reach A Solid Ground?

  26. What Are The Real Economic Costs Of Obesity?

  27. Gilead Sciences: The New Market-Share Leader

  28. A Checklist For Successful Medical Technology Investment

  29. Getting Started In Stocks

  30. Top 4 Most Scandalous Insider Trading Debacles

  31. 8 Stages Of New Drug Development

  32. Investing In Medical Equipment Companies

  33. Using DCF In Biotech Valuation

  34. Investing In The Biotech Sector

  35. 4 Reasons Why You Love To Hate Big Businesses

  36. Evaluating Pharmaceutical Companies

  37. A Primer On The Biotech Sector

  38. Government Regulations: Do They Help Businesses?

  39. 7 Popular Diet Plans And What They Cost

  40. Baby Boomers Beware: Financial Fraud That Targets Seniors

  41. Scandals That Bring The CEOs Out

  42. Infamous Female Financiers

  43. A Year In Product Recalls

  44. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  45. Investing In The Healthcare Sector

  46. Chasing Down Biotech Zombie Stocks

  47. The Ups And Downs Of Biotechnology

Trading Center